TARDIVE DYSKINESIA
Clinical trials for TARDIVE DYSKINESIA explained in plain language.
Never miss a new study
Get alerted when new TARDIVE DYSKINESIA trials appear
Sign up with your email to follow new studies for TARDIVE DYSKINESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for controlling debilitating involuntary movements
Disease control CompletedThis study tested whether a daily medication called MT-5199 could safely reduce the involuntary movements of tardive dyskinesia. Researchers enrolled 256 adults with moderate to severe symptoms who also had conditions like schizophrenia or bipolar disorder. Participants received …
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE2, PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for uncontrollable movements? drug study aims to ease debilitating side effect
Symptom relief CompletedThis study tested whether the drug valbenazine could improve daily life for people with tardive dyskinesia (TD), a condition causing uncontrollable movements often linked to certain mental health medications. For 24 weeks, 59 adults with TD and conditions like schizophrenia or bi…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Hope for patients with Drug-Induced movement disorder
Symptom relief CompletedThis study tested whether the medication tetrabenazine could reduce involuntary movements in people with tardive dyskinesia—a side effect caused by long-term antipsychotic use. Fifty-four adult patients were randomly assigned to receive either tetrabenazine or a placebo pill for …
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC